Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy
- PMID: 22633307
- PMCID: PMC3361732
- DOI: 10.1016/j.cardfail.2012.04.002
Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy
Abstract
Background: Transient changes in the composition of the myocardial extracellular matrix may contribute to the ventricular systolic dysfunction in stress-induced cardiomyopathy (SIC). We examined the changes in plasma matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) that occur early after the clinical presentation of SIC.
Methods and results: Ten patients with SIC were enrolled. Plasma concentrations of the 6 major MMPs (1, 2, 3, 7, 8, and 9) and all 4 TIMPs (1, 2, 3, and 4) were analyzed and compared with data from 15 control subjects. Within 24 hours of the clinical presentation, SIC patients had lower MMP-1 levels (0.41 ± 0.13 vs 0.70 ± 0.13 pg/mL; P = .048) and MMP-8 levels (1.61 ± 0.34 vs 4.84 ± 1.38 pg/mL; P = .001) and higher TIMP-4 levels (3.06 ± 0.40 vs 2.16 ± 0.18 pg/mL; P = .05) compared with control. Seven of 9 SIC patients had elevated LV end-diastolic pressures, and all had normal LV end-diastolic dimensions and volumes.
Conclusions: Patients afflicted with SIC had MMP and TIMP profiles similar to those described in hypertensive heart disease and diastolic heart failure and different from the profiles following myocardial infarction. Our findings uncovered a unique biomolecular profile in SIC during the first 24 hours of presentation.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.JAMA Netw Open. 2020 Dec 1;3(12):e2027754. doi: 10.1001/jamanetworkopen.2020.27754. JAMA Netw Open. 2020. PMID: 33258908 Free PMC article.
-
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).J Card Fail. 2007 Sep;13(7):530-40. doi: 10.1016/j.cardfail.2007.04.010. J Card Fail. 2007. PMID: 17826643 Free PMC article.
-
Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.Clin Sci (Lond). 2009 Jul 16;117(4):157-64. doi: 10.1042/CS20080278. Clin Sci (Lond). 2009. PMID: 19196241
-
Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.Heart Fail Rev. 2004 Jan;9(1):21-31. doi: 10.1023/B:HREV.0000011391.81676.3c. Heart Fail Rev. 2004. PMID: 14739765 Review.
-
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis.J Hypertens. 2012 Jan;30(1):3-16. doi: 10.1097/HJH.0b013e32834d249a. J Hypertens. 2012. PMID: 22134384 Review.
Cited by
-
Risk Factors Association with Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Genes in Patients with Heart Failure.Biomedicines. 2024 Mar 7;12(3):601. doi: 10.3390/biomedicines12030601. Biomedicines. 2024. PMID: 38540214 Free PMC article.
-
Transcriptional Activity of Metalloproteinase 9 (MMP-9) and Tissue Metalloproteinase 1 (TIMP-1) Genes as a Diagnostic and Prognostic Marker of Heart Failure Due to Ischemic Heart Disease.Biomedicines. 2023 Oct 13;11(10):2776. doi: 10.3390/biomedicines11102776. Biomedicines. 2023. PMID: 37893149 Free PMC article.
-
Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect.J Cardiovasc Dev Dis. 2023 Jul 21;10(7):313. doi: 10.3390/jcdd10070313. J Cardiovasc Dev Dis. 2023. PMID: 37504569 Free PMC article. Review.
-
Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers.Am J Physiol Heart Circ Physiol. 2022 May 1;322(5):H798-H805. doi: 10.1152/ajpheart.00497.2021. Epub 2022 Mar 11. Am J Physiol Heart Circ Physiol. 2022. PMID: 35275763 Free PMC article.
-
Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.Evid Based Complement Alternat Med. 2021 Oct 21;2021:6538189. doi: 10.1155/2021/6538189. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9830542. doi: 10.1155/2023/9830542. PMID: 34721639 Free PMC article. Retracted.
References
-
- Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21:203–14. - PubMed
-
- Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–9. - PubMed
-
- Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94:343–6. - PubMed
-
- Dec GW. Recognition of the apical ballooning syndrome in the United States. Circulation. 2005;111:388–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous